DekaBank Deutsche Girozentrale’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-13,100
Closed -$243K 1236
2017
Q4
$243K Hold
13,100
﹤0.01% 921
2017
Q3
$243K Hold
13,100
﹤0.01% 927
2017
Q2
$212K Hold
13,100
﹤0.01% 927
2017
Q1
$166K Sell
13,100
-1,100
-8% -$13.3K ﹤0.01% 858
2016
Q4
$181K Buy
14,200
+1,100
+8% +$18.8K ﹤0.01% 843
2016
Q3
$309K Hold
13,100
﹤0.01% 761
2016
Q2
$382K Sell
13,100
-23,700
-64% -$772K ﹤0.01% 729
2016
Q1
$1.19M Hold
36,800
0.01% 530
2015
Q4
$1.6M Buy
36,800
+700
+2% +$28K 0.02% 496
2015
Q3
$1.27M Buy
36,100
+1,400
+4% +$63.1K 0.02% 518
2015
Q2
$1.59M Buy
34,700
+1,300
+4% +$61.7K 0.02% 487
2015
Q1
$1.56M Sell
33,400
-4,500
-12% -$179K 0.02% 491
2014
Q4
$1.21M Sell
37,900
-3,500
-8% -$102K 0.02% 535
2014
Q3
$982K Buy
41,400
+1,200
+3% +$30.7K 0.01% 519
2014
Q2
$1.21M Sell
40,200
-3,300
-8% -$89K 0.02% 473
2014
Q1
$1.15M Buy
43,500
+4,300
+11% +$107K 0.02% 458
2013
Q4
$973K Buy
39,200
+1,000
+3% +$22.3K 0.02% 439
2013
Q3
$783K Buy
+38,200
New +$789K 0.01% 476

Other funds holding IPXL

DekaBank Deutsche Girozentrale's IPXL Position: Q1 2018 in Review

DekaBank Deutsche Girozentrale sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 13,100 shares — an estimated $243K sold.

DekaBank Deutsche Girozentrale first reported a position in IPXL in Q3 2013 and held it in 18 quarters. The position peaked at $1.6M in Q4 2015. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

  • DekaBank Deutsche Girozentrale reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 13,100 Impax Laboratories, Inc. shares in Q1 2018, an estimated $243K.
  • DekaBank Deutsche Girozentrale first reported a position in Impax Laboratories, Inc. in Q3 2013 and held it in 18 quarters.
  • DekaBank Deutsche Girozentrale's Impax Laboratories, Inc. position peaked at $1.6M in Q4 2015.
  • 188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2018, filed 3 May 2018.